Jefferies Lifts PT on Thermo Fisher Scientific (TMO) to $80
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
JPMorgan Upgrades Thermo Fisher Scientific (TMO) to Overweight
February 1, 2013 6:50 AM ESTJPMorgan upgraded Thermo Fisher Scientific (NYSE: TMO) from Neutral to Overweight with a price target of $80.00 (from $70.00).
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more... More
Thermo Fisher Scientific (TMO) Tops Q4 EPS by 8c; Guides FY13 EPS, Revs
January 31, 2013 6:13 AM ESTThermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $1.36, $0.08 better than the analyst estimate of $1.28. Revenue for the quarter came in at $3.26 billion versus the consensus estimate of $3.13 billion.
Sees FY2013 EPS of $5.32-$5.46, versus the consensus of $5.43. Thermo Fisher Scientific sees FY2013... More
